Next important phase in infectious diseases research in Liverpool launched
Professor Dame Sally Davies, former Chief Medical Officer and current UK Special Envoy on Antimicrobial Resistance, visited Liverpool today to help launch an ambitious new programme of AMR research at the University of Liverpool and Liverpool School of Tropical Medicine (LSTM).
As part of an ambitious new chapter for their Centre of Excellence in Infectious Diseases Research (CEIDR), the two institutions are stepping up efforts to tackle the AMR crisis and its impact on human health in Liverpool, the UK and globally.
During her visit, Dame Sally unveiled a plaque marking CEIDR’s new £3.5m NIHR Antimicrobial Resistance Laboratories. These state-of-the art laboratories will provide the infrastructure needed for Liverpool researchers to develop personalised antimicrobial therapies to prevent and treat AMR.
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.